Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Jun;28(3):708–712. doi: 10.1128/iai.28.3.708-712.1980

Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon.

R Lazar, M K Breinig, J A Armstrong, M Ho
PMCID: PMC551008  PMID: 6156904

Abstract

First- and third-generation cloned progeny viruses were derived from clinical isolates of herpes simplex virus and examined for their sensitivities to human interferon by inhibition of plaque formation in Vero cells. The dose-response curves obtained with the first- and third-generation clones were similar to those obtained with the parental isolates, and both the parent and the clones showed similar sensitivities to interferon. These results suggest that clinical isolates of herpes simplex virus consist of a homogeneous population of virus particles with respect to interferon sensitivity. The dose-response curves obtained with herpes simplex virus demonstrated a shallower slope than those obtained with vesicular stomatitis virus. Vesicular stomatitis virus plaque formation as completely inhibited at high concentrations of interferon, whereas complete inhibition of plaque formation by herpes simplex virus did not occur at the highest concentration of interferon used. Cloned progeny were derived from plaques appearing in the presence of high concentrations of interferon. The dose-response curves and interferon sensitivities of these clones were similar to those of the parent and third-generation clone from which they were derived. There was no evidence for genetic heterogeneity with respect to interferon sensitivity.

Full text

PDF
708

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A. Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol. 1971 Apr;21(4):723–725. doi: 10.1128/am.21.4.723-725.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Desmyter J., Melnick J. L., Rawls W. E. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol. 1968 Oct;2(10):955–961. doi: 10.1128/jvi.2.10.955-961.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gifford G. E., Koch A. L. The interferon dose response curve and its possible significance. J Theor Biol. 1969 Feb;22(2):271–283. doi: 10.1016/0022-5193(69)90005-8. [DOI] [PubMed] [Google Scholar]
  4. Glasgow L. A., Hanshaw J. B., Merigan T. C., Petralli J. K. Interferon and cytomegalovirus in vivo and in vitro. Proc Soc Exp Biol Med. 1967 Jul;125(3):843–849. doi: 10.3181/00379727-125-32220. [DOI] [PubMed] [Google Scholar]
  5. HO M., ENDERS J. F. Further studies on an inhibitor of viral activity appearing in infected cell cultures and its role in chronic viral infections. Virology. 1959 Nov;9:446–477. doi: 10.1016/0042-6822(59)90135-7. [DOI] [PubMed] [Google Scholar]
  6. Hallum J. V., Thacore H. R., Youngner J. S. Factors affecting the sensitivity of different viruses to interferon. J Virol. 1970 Aug;6(2):156–162. doi: 10.1128/jvi.6.2.156-162.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ito Y., Montagnier L. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons. Infect Immun. 1977 Oct;18(1):23–27. doi: 10.1128/iai.18.1.23-27.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kern E. R., Glasgow L. A. Effect of interferon on systemic herpesvirus infections. Tex Rep Biol Med. 1977;35:472–477. [PubMed] [Google Scholar]
  9. Kern E. R., Overall J. C., Jr, Glasgow L. A. Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid. Antimicrob Agents Chemother. 1975 Jun;7(6):793–800. doi: 10.1128/aac.7.6.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marks-Hellman S., Ho M. Use of biological characteristics to type Herpesvirus hominis types 1 and 2 in diagnostic laboratories. J Clin Microbiol. 1976 Mar;3(3):277–280. doi: 10.1128/jcm.3.3.277-280.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Metz D. H., Douglas A. R. Viral resistance to interferon. Tex Rep Biol Med. 1977;35:260–263. [PubMed] [Google Scholar]
  12. Pazin G. J., Armstrong J. A., Lam M. T., Tarr G. C., Jannetta P. J., Ho M. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med. 1979 Aug 2;301(5):225–230. doi: 10.1056/NEJM197908023010501. [DOI] [PubMed] [Google Scholar]
  13. Rasmussen L., Farley L. B. Inhibition of Herpesvirus hominis replication by human interferon. Infect Immun. 1975 Jul;12(1):104–108. doi: 10.1128/iai.12.1.104-108.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Takemoto K. K., Baron S. Non-heritable interferon resistance in a fraction of virus populations. Proc Soc Exp Biol Med. 1966 Mar;121(3):670–675. doi: 10.3181/00379727-121-30857. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES